XENE filings
Corporate insider profile
Thomas Patrick Kelly Filing Activity
Latest reported as Chief Financial Officer of Xenon Pharmaceuticals Inc. (XENE).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $559,740
- Latest transaction
- Sep 30, 2026
Affiliated corporations
Reported company relationships
Transaction history
